-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RJ/JBf9/8FOzTqJsfQ8QcAnf8EaKN5rdzhjbjqJHQ3uGdwqcxMfQ61sRVl+FBM9x
 CQjrd2s8Ln6BVy3cc0Pk0A==

<SEC-DOCUMENT>0001096906-05-000077.txt : 20050302
<SEC-HEADER>0001096906-05-000077.hdr.sgml : 20050302
<ACCEPTANCE-DATETIME>20050302134037
ACCESSION NUMBER:		0001096906-05-000077
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20050302
ITEM INFORMATION:		Regulation FD Disclosure
FILED AS OF DATE:		20050302
DATE AS OF CHANGE:		20050302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12575
		FILM NUMBER:		05653445

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>utahmed8k030205.txt
<TEXT>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934


         Date of Report (date of earliest event reported): March 2, 2005


                           Commission File No. 0-11178
                                               -------


                           UTAH MEDICAL PRODUCTS, INC.
                           ---------------------------
             (Exact name of Registrant as specified in its charter)


               UTAH                                         87-0342734
  -------------------------------                      ------------------
  (State or other jurisdiction of                       (I.R.S. Employer
   incorporation or organization)                       Identification No.)


                               7043 South 300 West
                               Midvale, Utah 84047
                     ---------------------------------------
                     Address of principal executive offices


Registrant's telephone number:      (801) 566-1200
                                    --------------









<PAGE>


- --------------------------------------------------------------------------------

                      ITEM 7.01 - REGULATION FD DISCLOSURE

- --------------------------------------------------------------------------------


     The U.S. Court has granted the government's (FDA's/plaintiff's) Motion for
an Extension of Time for Discovery, and modified the Scheduling Order in Case
No. 2:04CV00733 BSJ. UTMD is the defendant in this case.

     All discovery is to be completed by May 2, 2005. This represents a two
month extension from the prior schedule.

     The final pretrial conference is scheduled for June 20, 2005. This
represents a five week extension from the prior schedule.

     Under SEC Fair Disclosure regulations, the Company feels it needs to
disseminate this information.





- --------------------------------------------------------------------------------

                                   SIGNATURES

- --------------------------------------------------------------------------------



   Pursuant to the requirements of the Securities Exchanges Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                            UTAH MEDICAL PRODUCTS, INC.
                                            ---------------------------
                                            REGISTRANT




Date:       3/02/05                         By: \s\ Kevin L. Cornwell
      -------------------                      -------------------------
                                               Kevin L. Cornwell
                                               Chairman & CEO


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
